Back

Medscape, LLC

  • Hemophilia A

Hemophilia at the Crossroads: New Evidence for Individualized Care

The goal of this activity is for learners to be better able to apply emerging evidence to assess treatment success beyond bleeding rates, prioritizing joint outcomes and quality of life; differentiate clinically meaningful features of available therapies; integrate patient goals and physical activity considerations into treatment selection; and individualize care decisions to improve patient-relevant outcomes in hemophilia A and B.

Credit & MOC Details

Credit information is provided by the course provider. We recommend confirming credit eligibility with the provider or your licensing board before starting the activity.

Credit types

AMA PRA Category 1 Credit™Up to 1.5 creditsNursingUp to 1.5 creditsPharmacyUp to 1.5 credits

MOC types

No MOC

FDA REMS

No

Qualifies for MIPS

No
Start Date
December 11, 2026
End Date
January 9, 2027

Pricing

Free

Reported to ACCME by the provider

  • Live
  • Credit · Up to 1.5 credits
  • Commercial Support
  • When
    Dec 11, 2026 – Jan 8, 2027